April 3 (Reuters) - AbbVie ABBV.N on Thursday cut its 2025 adjusted profit forecast as the drugmaker expects to incur $248 million in acquisition-related expenses.
The company expects adjusted profit in the range of $11.99 to $12.19 per share, compared with its previous forecast of $12.12 to $12.32 per share.
(Reporting by Puyaan Singh in Bengaluru; Editing by Shreya Biswas)
((Puyaan.Singh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.